以岭药业

- 002603

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
以岭药业(002603) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入460,448.58252,263.271,031,831.29857,467.83679,056.16
营业收入460,448.58252,263.271,031,831.29857,467.83679,056.16
二、营业总成本397,887.13216,333.10871,919.63657,676.15490,393.41
营业成本214,715.82122,406.07440,780.91334,304.84259,836.38
营业税金及附加7,195.624,432.2313,512.7511,021.617,869.04
销售费用107,791.9556,776.37270,466.24208,997.44152,465.29
管理费用27,138.2313,815.6359,204.1843,036.0829,488.54
财务费用1,716.54843.572,636.81945.31473.30
研发费用39,328.9818,059.2585,318.7359,370.8840,260.87
资产减值损失----------
公允价值变动收益2,590.591,295.303,935.384,442.562,770.01
投资收益92.73381.462,595.04-38.96256.22
其中:对联营企业和合营企业的投资收益-0.62-0.29-1.51-1.00-0.98
汇兑收益----------
三、营业利润67,095.8839,139.43177,982.75212,871.21193,835.98
加:营业外收入119.9082.65843.96386.17275.88
减:营业外支出2,883.572,376.5110,405.582,648.44772.71
其中:非流动资产处置损失----------
四、利润总额64,332.2136,845.56168,421.14210,608.93193,339.15
减:所得税费用11,669.576,653.5933,990.8735,215.2633,034.12
五、净利润52,662.6430,191.97134,430.27175,393.67160,305.03
归属于母公司所有者的净利润53,045.7130,392.79135,237.92175,868.44160,602.10
少数股东损益-383.07-200.82-807.66-474.77-297.07
六、每股收益
基本每股收益(元/股)0.31750.18190.80951.05270.9613
稀释每股收益(元/股)0.31750.18190.80951.05270.9613
七、其他综合收益2.06-3.3260.4689.4099.38
八、综合收益总额52,664.7030,188.65134,490.73175,483.08160,404.41
归属于母公司所有者的综合收益总额53,047.7730,389.47135,298.38175,957.84160,701.48
归属于少数股东的综合收益总额-383.07-200.82-807.66-474.77-297.07
下载全部历史数据到excel中 返回页顶